Monopar Therapeutics
MNPR
MNPR
13 hedge funds and large institutions have $484K invested in Monopar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$24.5K | |
| 2 | -$2.51K | |
| 3 | -$1K | |
| 4 |
Morgan Stanley
New York
|
-$11 |